[1] Herman WH, Ilag LL, Johnson SL, et al. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes. Diabetes Care. 2005;28(7):1568-1573.[2] Kizilel S, Garfinkel M, Opara E. The bioartificial pancreas: progress and challenges. Diabetes Technol Ther. 2005; 7(6): 968-985.[3] Malaise J, Steurer W, Koenigsrainer A, et al. Simultaneous pancreas-kidney transplantation in a large multicenter study: surgical complications. Transplant Proc. 2005;37(6): 2859-2860.[4] Menger MD, Yamauchi J, Vollmar B. Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg. 2001;25(4):509-515.[5] Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes. 2002;51(5):1362-1366.[6] 谭建明.成人胰岛细胞移植的临床进展[J].中华器官移植杂志, 2008,29(4):250-252.[7] 江学良,李兆申.骨髓间充质干细胞在大鼠急性坏死性胰腺炎并发多脏器功能障碍综合症中的作用[J].中华胰腺病杂志,2008, 8(6):401-404.[8] Yen CC, Yang SH, Lin CY, et al. Stem cells in the lung parenchyma and prospects for lung injury therapy. Eur J Clin Invest. 2006;36(5):310-319.[9] Keating A. Mesenchymal stromal cells. Curr Opin Hematol. 2006;13(6):419-425.[10] 杨丽霞,刘铜华,王志程,等.骨髓间充质干细胞诱导分化为胰岛细胞的研究进展[J].疑难病杂志,2008,7(12):764-766.[11] 沈浩亮,王志伟,朱铭岩,等.体外共培养诱导骨髓间充质干细胞向胰岛样细胞分化[J].中华胰腺病杂志,2008,8(6):397-400.[12] Choi KS, Shin JS, Lee JJ, et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun. 2005; 330(4):1299-1305.[13] Oh SH, Muzzonigro TM, Bae SH, et al. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Invest. 2004;84(5):607-617.[14] Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003;21(7): 763-770.[15] Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest. 2003; 111(6):843-850. [16] Lu Y, Wang Z, Zhu M. Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably. Ann Clin Lab Sci. 2006;36(2):127-136.[17] Mathews V, Hanson PT, Ford E, et al. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes. 2004;53(1):91-98.[18] Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A. 2000; 97(21):11307-11312.[19] Hart AW, Baeza N, Apelqvist A, et al. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature. 2000; 408(6814):864-868.[20] Woodbury D, Schwarz EJ, Prockop DJ, et al. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364-370.[21] Xu J, Lu Y, Ding F, et al. Reversal of diabetes in mice by intrahepatic injection of bone-derived GFP-murine mesenchymal stem cells infected with the recombinant retrovirus-carrying human insulin gene. World J Surg. 2007; 31(9):1872-1882.[22] 陈建,王志伟,朱铭岩,等.骨髓间充质干细胞在糖尿病模型鼠体内分布及归巢[J].中华胰腺病杂志,2009,9(1):56-58.[23] Xu YX, Chen L, Wang R, et al. Mesenchymal stem cell therapy for diabetes through paracrine mechanisms. Med Hypotheses. 2008;71(3):390-393.[24] Soria B, Roche E, Berná G, et al. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes. 2000;49(2): 157-162.[25] 徐丽丽,杨乃龙.成人骨髓间充质干细胞体外诱导分化为胰岛样细胞的研究进展[J].中国组织工程研究与临床康复,2008,12(8): 1509-1512. |